These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 24094493)
41. NIH and WHI: time for a mea culpa and steps beyond. Utian WH Menopause; 2007; 14(6):1056-9. PubMed ID: 17975521 [TBL] [Abstract][Full Text] [Related]
42. Risks of hormone therapy in the 50-59 year age group. van de Weijer PH Maturitas; 2008 May; 60(1):59-64. PubMed ID: 18556157 [TBL] [Abstract][Full Text] [Related]
43. Issues to debate on the Women's Health Initiative: failure of estrogen plus progestin therapy for prevention of breast cancer risk. Luukkainen T Hum Reprod; 2003 Aug; 18(8):1559-61. PubMed ID: 12871861 [TBL] [Abstract][Full Text] [Related]
44. What happened to WHI: menopausal hormonal therapy in 2012. Hansen KA; Eyster KM Clin Obstet Gynecol; 2012 Sep; 55(3):706-12. PubMed ID: 22828102 [TBL] [Abstract][Full Text] [Related]
47. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study. Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG Menopause; 2006; 13(1):125-9. PubMed ID: 16607108 [TBL] [Abstract][Full Text] [Related]
48. A critique of the Women's Health Initiative hormone therapy study. Klaiber EL; Vogel W; Rako S Fertil Steril; 2005 Dec; 84(6):1589-601. PubMed ID: 16359951 [TBL] [Abstract][Full Text] [Related]
50. Introduction: menopausal hormone therapy: where are we today? Cedars MI Fertil Steril; 2014 Apr; 101(4):885-6. PubMed ID: 24613540 [TBL] [Abstract][Full Text] [Related]
51. On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause. Langer RD Climacteric; 2010 Aug; 13(4):303-6. PubMed ID: 20540591 [TBL] [Abstract][Full Text] [Related]
52. Quality of life and the role of menopausal hormone therapy. Pines A; Sturdee DW; MacLennan AH Climacteric; 2012 Jun; 15(3):213-6. PubMed ID: 22612606 [TBL] [Abstract][Full Text] [Related]
53. Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid. Udell JA; Fischer MA; Brookhart MA; Solomon DH; Choudhry NK J Bone Miner Res; 2006 May; 21(5):765-71. PubMed ID: 16734392 [TBL] [Abstract][Full Text] [Related]
54. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence. Harman SM; Naftolin F; Brinton EA; Judelson DR Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750 [TBL] [Abstract][Full Text] [Related]
55. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice. Schonberg MA; Wee CC J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005 [TBL] [Abstract][Full Text] [Related]
56. Be careful of what you wish for: putting the WHI Estrogen/Progestin and HERS II Trials in perspective. Randolph JF; Medscape Womens Health; 2002; 7(4):7. PubMed ID: 12466739 [No Abstract] [Full Text] [Related]
57. Re-think HRT: behind the scene of perceptions. Pines A Climacteric; 2008; 11(6):443-6. PubMed ID: 18991073 [No Abstract] [Full Text] [Related]
59. Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment. Flores VA; Pal L; Manson JE Endocr Rev; 2021 Nov; 42(6):720-752. PubMed ID: 33858012 [TBL] [Abstract][Full Text] [Related]
60. Lessons from the skeleton: was the Women's Health Initiative (WHI) a primary prevention trial? Kleerekoper M Osteoporos Int; 2002 Sep; 13(9):685-7. PubMed ID: 12195531 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]